Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...
During this period, the Zacks Medical - Products industry, which Abbott falls in, has lost 0.6%. The key question now is: What could be the stock's future direction? While media releases or rumors ...
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...
Abbott Laboratories (NYSE:ABT – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders bought 71,494 call options on the company. This is an increase ...
Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry ...